Approvals/TGA/MALARONE JUNIOR TABLETS (62.5/25) atovaquone and proguanil hydrochloride tablet blister pack

Approved

STANDARD

MALARONE JUNIOR TABLETS (62.5/25) atovaquone and proguanil hydrochloride tablet blister pack

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3f626a9d0cc811bc
Product Name: MALARONE JUNIOR TABLETS (62.5/25) atovaquone and proguanil hydrochloride tablet blister pack
Artg Id: 92855
Artg Name: MALARONE JUNIOR TABLETS (62.5/25) atovaquone and proguanil hydrochloride tablet blister pack
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2003-03-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04713-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04712-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3f626a9d0cc811bc

Type

Standard